An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
1 other identifier
interventional
12
1 country
1
Brief Summary
Fluoride is very effective in preventing dental decay (cavities) when applied in the form of a varnish on tooth surfaces. The purpose of this study is to verify if fluoride-releasing primer (OpalSeal) offers more protection against early dental decay (cavity) compared to conventional primer (Transbond XT) during treatment with braces.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2017
CompletedFirst Submitted
Initial submission to the registry
October 25, 2018
CompletedFirst Posted
Study publicly available on registry
October 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 12, 2019
CompletedResults Posted
Study results publicly available
February 25, 2020
CompletedMarch 4, 2020
February 1, 2020
1.4 years
October 25, 2018
January 17, 2020
February 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Loss of Mineral Density in the Enamel
Teeth will be subjected to microCT to assess the extent of demineralization. Loss of mineral density will be measured as depth of lesions
Time from initial bonding to extraction (max 90 days)
Secondary Outcomes (2)
Surface Topography and Hardness
Time from initial bonding to extraction (max 90 days)
Retention of OpalSeal
Time from initial bonding to extraction (max 90 days)
Study Arms (2)
OpalSeal
EXPERIMENTALOpalSeal will be applied 1. to the buccal surfaces of to-be-extracted teeth on one side of the mouth which will be determined randomly for each participant during bonding of orthodontic brackets, or 2. to the proximal surfaces following IPR in accordance to manufacturer instructions. Since OpalSeal has fluoride releasing capability, this would be experimental arm
Transbond XT
PLACEBO COMPARATORTransbondXT will be applied 1. to the buccal surfaces of to-be-extracted teeth on the other side of the mouth which will be determined based on which side received OpalSeal for each participant during bonding of orthodontic brackets, or 2. to the proximal surfaces following IPR in accordance to manufacturer instructions. Transbond XT does not have fluoride and hence would be considered as a placebo.
Interventions
OpalSeal is a fluoride releasing orthodontic primer that is FDA approved for use during bonding of orthodontic brackets
Transbond is a primer used to bond orthodontic brackets that does not contain fluoride
Eligibility Criteria
You may qualify if:
- Patients age 10 and older seeking treatment at the VCU Orthodontics Clinic who require extraction of at least 2 teeth for orthodontic purposes
- Such teeth should be free of any developmental defects
You may not qualify if:
- Patients under 10 years of age
- Patients with defective teeth
- Those who cannot provide consent/assent OR not able to follow research protocols
- Protected population (prisoners)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Dentistry, Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Eser Tufekci, DDS, PhD
- Organization
- Virginia Commonwealth University
Study Officials
- PRINCIPAL INVESTIGATOR
Parthasarathy Madurantakam, DDS
Virginia Commonwealth University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Opalseal and TransbondXT are identical in color, consistency and application allowing random assignments as well as patient blinding. The outcomes assessor will also be blinded to the groups assignments.
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2018
First Posted
October 26, 2018
Study Start
November 16, 2017
Primary Completion
April 12, 2019
Study Completion
April 12, 2019
Last Updated
March 4, 2020
Results First Posted
February 25, 2020
Record last verified: 2020-02